Endoscopic Bariatric Treatment with Duodenal-Jejunal Bypass Liner Improves Non-invasive Markers of Non-alcoholic Steatohepatitis.

Thomas KarlasDavid PetroffJürgen FeisthammelSebastian BeerMatthias BlüherTatjana SchützRalf LichtinghagenAlbrecht HoffmeisterJohannes Wiegand

Published in: Obesity surgery (2022)

One year of DJBL therapy is associated with relevant improvements in non-invasive markers of steatosis and NASH, but not fibrosis, and is accompanied by a substantial number of complications. Given the lack of alternatives, DJBL deserves further attention.

Keyphrases

weight loss
working memory
insulin resistance
ultrasound guided
high fat diet
liver injury
roux en y gastric bypass
stem cells
metabolic syndrome
bariatric surgery
combination therapy
drug induced